Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alkermes Announces Positive Topline Results From Phase 1b Study Of ALKS 2680 In Patients With Narcolepsy Type 2 And Idiopathic Hypersomnia

Author: Benzinga Newsdesk | April 09, 2024 07:03am

Posted In: ALKS